arrow
A

Abraham Ka Chung Wai

university of hong kong
H指数:27
被引数:1,988

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Differential survival impact of acetaminophen and non-steroidal anti-inflammatory drugs on NSCLC patients undergoing immune checkpoint inhibitor therapy: a region-wide cohort study in Hong Kong, China

对接受免疫检查点抑制剂治疗的NSCLC患者,乙酰氨基酚与非甾体抗炎药差异化生存影响的区域队列研究:中国香港地区

2026-02-150
OAAI
Postpandemic Change in Demographic and Clinical Features of Patients With Omicron Who Were Hospitalized: Territory-Wide Retrospective Repeated Cross-Sectional Study in Hong Kong

后疫情时代奥密克戎住院患者的流行病学和临床特征变化:香港全境回顾性重复横断面研究

2026-02-130
PRE
Antibiotic stewardship in suspected neutropenic fever (ASTERIC trial): a multicentre, type 1 hybrid effectiveness-implementation, stepped-wedge, randomised controlled trial study protocol

抗菌药物合理使用在疑似中性粒细胞减少性发热中的应用(ASTERIC试验):一项多中心、I型混合效果-实施、阶梯式楔形随机对照试验研究方案

2025-11-240
OA
Incidence of Deliberate Self-Harm in Hong Kong Before and During the COVID-19 Pandemic: Population-Wide Retrospective Cohort Study

新型冠状病毒肺炎大流行之前和期间香港自伤的发病率: 全人群回顾性队列研究

2025-02-100
OAAI
New-onset syncope in diabetic patients treated with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors: a Chinese population-based cohort study

接受钠-葡萄糖cotransporter-2抑制剂与二肽基peptidase-4抑制剂治疗的糖尿病患者新发晕厥: 一项基于中国人群的队列研究

2023-11-142
OA
Association of Molnupiravir and Nirmatrelvir-Ritonavir with reduced mortality and sepsis in hospitalized omicron patients: a territory-wide study
2023-05-153
OAAI
Association of Molnupiravir and Nirmatrelvir-Ritonavir with preventable mortality, hospital admissions and related avoidable healthcare system cost among high-risk patients with mild to moderate COVID-19
2023-01-0164
OAAI